Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy

  • Authors:
    • Yan Wang
    • Zhiping Li
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, Children's Hospital of Fudan University, Shanghai 201102, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 373-383
    |
    Published online on: April 30, 2019
       https://doi.org/10.3892/etm.2019.7538
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Epilepsy is the most common chronic neurological disorder, affecting ~70 million individuals worldwide. However, approximately one‑third of the patients are refractory to epilepsy medication. Of note, 100% of patients with genetic epilepsy who are resistant to the traditional drug, valproic acid (VPA), are also refractory to the other anti‑epileptic drugs. The aim of the present study was to compare the transcriptomes in VPA responders and non‑responders, to explore the mechanism of action of VPA and identify possible biomarkers to predict VPA resistance. Thus, RNA‑seq was employed for transcriptomic analysis, differentially expressed genes (DEGs) were analyzed using Cuffdiff software and the DAVID database was used to infer the functions of the DEGs. A protein‑protein interaction network was obtained using STRING and visualized with Cytoscape. A total of 389 DEGs between VPA‑responsive and non‑responsive pediatric patients were identified. Of these genes, 227 were upregulated and 162 were downregulated. The upregulated DEGs were largely associated with cytokines, chemokines and chemokine receptor‑binding factors, whereas the downregulated DEGs were associated with cation channels, iron ion binding proteins, and immunoglobulin E receptors. In the pathway analysis, the toll‑like receptor signaling pathway, pathways in cancer, and cytokine‑cytokine receptor interaction were mostly enriched by the DEGs. Furthermore, three modules were identified by protein‑protein interaction analysis, and the potential hub genes, chemokine (C‑C motif) ligand 3 and 4, chemokine (C‑X‑C motif) ligand 9, tumor necrosis factor‑α and interleukin‑1β, which are known to be closely associated with epilepsy, were identified. These specific chemokines may participate in processes associated with VPA resistance and may be potential biomarkers for monitoring the efficacy of VPA.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Singh A and Trevick S: The epidemiology of global epilepsy. Neurol Clin. 34:837–847. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Lv RJ, Shao XQ, Cui T and Wang Q: Significance of MDR1 gene C3435T polymorphism in predicting childhood refractory epilepsy. Epilepsy Res. 132:21–28. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Voll A, Hernández-Ronquillo L, Buckley S and Téllez-Zenteno JF: Predicting drug resistance in adult patients with generalized epilepsy: A case-control study. Epilepsy Behav. 53:126–130. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Rakitin A, Kõks S and Haldre S: Valproate modulates glucose metabolism in patients with epilepsy after first exposure. Epilepsia. 56:e172–e175. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Fernando-Dongas MC, Radtke RA, Vanlandingham KE and Husain AM: Characteristics of valproic acid resistant juvenile myoclonic epilepsy. Seizure. 9:385–388. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Nevitt ST, Sudell M, Weston J, Tudur Smith C and Marson AG: Antiepileptic drug monotherapy for epilepsy: A network meta-analysis of individual participant data. Cochrane Database Syst Rev. 6:CD01141212017.

7 

Brigo F, Igwe SC and Lattanzi S: Ethosuximide, sodium valproate or lamotrigine for absence seizure in children and adolescents. Cochrane Database Syst Rev. 2:CD0030322019.PubMed/NCBI

8 

Yasiry Z and Shorvon SD: The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure. 23:167–174. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Trinka E, Höfler J, Zerbs A and Brigo F: Efficacy and safety of intravenous valproate for status epilepticus: A systematic review. CNS Drugs. 28:623–639. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Gesche J, Khanevski M, Solberg C and Beier CP: Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies. Epilepsia. 58:E64–E69. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Luna-Tortós C, Fedrowitz M and Löscher W: Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 58:1019–1032. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Baltes S, Fedrowitz M, Tortos CL, Potschka H and Löscher W: Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther. 320:331–343. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Moerman L, Wyffels L, Slaets D, Raedt R, Boon P and De Vos F: Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with (11)C-desmethylloperamide. Epilepsy Res. 94:18–25. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Römermann K, Helmer R and Löscher W: The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2). Neuropharmacology. 93:7–14. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Zhou L, Cao Y, Long H, Long L, Xu L, Liu Z, Zhang Y and Xiao B: ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population. Pharmazie. 70:416–420. 2015.PubMed/NCBI

16 

Balan S, Sathyan S, Radha SK, Joseph V, Radhakrishnan K and Banerjee M: GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures. Pharmacogenet Genomics. 23:605–610. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Singh E, Pillai KK and Mehndiratta M: Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: Evaluation of drug resistance mechanisms. Basic Clin Pharmacol Toxicol. 115:373–378. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Glauser TA, Holland K, O'Brien VP, Keddache M, Martin L, Clark PO, Cnaan A, Dlugos D, Hirtz DG6 Shinnar S, et al: Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. Ann Neurol. 81:444–453. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Lv N, Qu J, Long H, Zhou L, Cao Y, Long L, Liu Z and Xiao B: Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population. Seizure. 30:64–69. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Mou P, Chen Z, Jiang L, Cheng J and Wei R: PTX3: A potential biomarker in thyroid associated ophthalmopathy. Biomed Res Int. 2018:59619742018. View Article : Google Scholar : PubMed/NCBI

21 

Waters WR, Maggioli MF, Palmer MV, Thacker TC, McGill JL, Vordermeier HM, Berney-Meyer L, Jacobs WR Jr and Larsen MH: Interleukin-17A as a Biomarker for bovine tuberculosis. Clin Vaccine Immunol. 23:168–180. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Satoh J, Yamamoto Y, Asahina N, Kitano S and Kino Y: RNA-Seq data mining: Downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains. Dis Markers. 2014:1231652014. View Article : Google Scholar : PubMed/NCBI

23 

Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, et al: F11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One. 8:e775712013. View Article : Google Scholar : PubMed/NCBI

24 

Dixit AB, Banerjee J, Srivastava A, Tripathi M, Sarkar C, Kakkar A, Jain M and Chandra PS: RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS. Genomics. 107:178–188. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Griffin NG, Wang Y, Hulette CM, Halvorsen M, Cronin KD, Walley NM, Haglund MM, Radtke RA, Skene JH, Sinha SR and Heinzen EL: Differential gene expression in dentate granule cells in mesial temporal lobe epilepsy with and without hippocampal sclerosis. Epilepsia. 57:376–385. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Liew CC, Ma J, Tang HC, Zheng R and Dempsey AA: The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. J Lab Clin Med. 147:126–132. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV and Krainc D: Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA. 102:11023–11028. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Jergil M, Forsberg M, Salter H, Stockling K, Gustafson AL, Dencker L and Stigson M: Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. Toxicol Sci. 121:328–342. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Dozawa M, Kono H, Sato Y, Ito Y, Tanaka H and Ohshima T: Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum. Dev Dyn. 243:1401–1415. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Van Lint C, Emiliani S and Verdin E: The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:245–253. 1996.PubMed/NCBI

31 

Rakitin A, Kõks S, Reimann E, Prans E and Haldre S: Changes in the peripheral blood gene expression profile induced by 3 months of valproate treatment in patients with newly diagnosed epilepsy. Front Neurol. 6:1882015. View Article : Google Scholar : PubMed/NCBI

32 

Floriano-Sánchez E, Brindis F, Ortega-Cuellar D, Ignacio-Mejía I, Moreno-Arriola E, Romero-Morelos P, Ceballos-Vasquez E, Córdova-Espinoza MG, Arregoitia-Sarabia CK, Sandoval-Pacheco R, et al: Differential gene expression profile induced by valproic acid (VPA) in pediatric epileptic patients. Genes (Basel). 9(pii): E3282018. View Article : Google Scholar : PubMed/NCBI

33 

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S and French J: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic Strategies. Epilepsia. 51:1069–1077. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, et al: Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia. 51:676–685. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki RA: The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI

37 

Brahma R, Gurumayum S, Naorem LD, Muthaiyan M, Gopal J and Venkatesan A: Identification of hub genes and pathways in Zika Virus infection using RNA-Seq Data: A network-based computational approach. Viral Immunol. 31:321–332. 2018. View Article : Google Scholar : PubMed/NCBI

38 

Kan AA, de Jager W, de Wit M, Heijnen C, van Zuiden M, Ferrier C, van Rijen P, Gosselaar P, Hessel E, van Nieuwenhuizen O and de Graan PN: Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines. J Neuroinflammation. 9:2072012. View Article : Google Scholar : PubMed/NCBI

39 

Louboutin JP, Chekmasova A, Marusich E, Agrawal L and Strayer DS: Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 25:737–753. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Pocock JM and Liddle AC: Microglial signalling cascades in neurodegenerative disease. Prog Brain Res. 132:555–565. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Chui R and Dorovini-Zis K: Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J Neuroinflammation. 7:12010. View Article : Google Scholar : PubMed/NCBI

42 

De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S and Vezzani A: Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci. 12:2623–2633. 2000. View Article : Google Scholar : PubMed/NCBI

43 

Jin W, Zhang J, Lou D, Chavkin C and Xu M: C-fos-deficient mouse hippocampal CA3 pyramidal neurons exhibit both enhanced basal and kainic acid-induced excitability. Neurosci Lett. 331:151–154. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Zhang J, Zhang D, McQuade JS, Behbehani M, Tsien JZ and Xu M: c-fos regulates neuronal excitability and survival. Nat Genet. 30:416–420. 2002. View Article : Google Scholar : PubMed/NCBI

45 

Tang Y, Glauser TA, Gilbert DL, Hershey AD, Privitera MD, Ficker DM, Szaflarski JP and Sharp FR: Valproic acid blood genomic expression patterns in children with epilepsy-a pilot study. Acta Neurol Scand. 109:159–168. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Minnier J, Pennock ND, Guo Q, Schedin P and abd Harrington CA: RNA-Seq and expression arrays: Selection guidelines for genome-wide expression profiling. Methods Mol Bio. 1783:7–33. 2018. View Article : Google Scholar

47 

Zhao S, Fung-Leung WP, Bittner A, Ngo K and Liu X: Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One. 9:e786442014. View Article : Google Scholar : PubMed/NCBI

48 

Walker L and Sills GJ: Inflammation and epilepsy: The foundations for a new therapeutic approach in epilepsy? Epilepsy Curr. 12:8–12. 2012. View Article : Google Scholar : PubMed/NCBI

49 

Guzik-Kornacka A, Sliwa A, Plucinska G and Lukasiuk K: Status epilepticus evokes prolonged increase in the expression of CCL3 and CCL4 mRNA and protein in the rat brain. Acta Neurobiol Exp (Wars). 71:193–207. 2011.PubMed/NCBI

50 

Owens GC, Huynh MN, Chang JW, McArthur DL, Hickey MJ, Vinters HV, Mathern GW and Kruse CA: Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation. 10:562013. View Article : Google Scholar : PubMed/NCBI

51 

Arisi GM, Foresti ML, Katki K and Shapiro LA: Increased CCL2, CCL3, CCL5, and IL-1β cytokine concentration in piriform cortex, hippocampus, and neocortex after pilocarpine-induced seizures. J Neuroinflammation. 12:1292015. View Article : Google Scholar : PubMed/NCBI

52 

Srivastava A, Dixit AB, Paul D, Tripathi M, Sarkar C, Chandra PS and Banerjee J: Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD). Sci Rep. 7:159042017. View Article : Google Scholar : PubMed/NCBI

53 

Saber S, Mahmoud AAA, Helal NS, El-Ahwany E and Abdelghany RH: Renin-angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B. Can J Physiol Pharmacol. 96:569–576. 2018. View Article : Google Scholar : PubMed/NCBI

54 

Guenther S, Bauer S, Hagge M, Knake S, Olmes DG, Tackenberg B, Rosenow F and Hamer HM: Chronic valproate or levetiracetam treatment does not influence cytokine levels in humans. Seizure. 23:666–669. 2014. View Article : Google Scholar : PubMed/NCBI

55 

Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T and Furukawa S: Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 857:246–251. 2000. View Article : Google Scholar : PubMed/NCBI

56 

Ghosh C, Hossain M, Solanki J, Najm IM, Marchi N and Janigro D: Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 58:576–585. 2017. View Article : Google Scholar : PubMed/NCBI

57 

Lee NY, Riechmann P and Kang YS: The changes of P-glycoprotein activity by interferon-γ and tumor necrosis factor-α in primary and immortalized human brain microvascular endothelial cells. Blomol Ther (Seoul). 20:293–298. 2012. View Article : Google Scholar

58 

Feng W, Mei S, Zhu L, Yu Y, Yang W, Gao B, Wu X, Zhao Z and Feng F: Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures. Seizure. 58:96–100. 2018. View Article : Google Scholar : PubMed/NCBI

59 

Mantle JL and Lee KH: A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model. Neurobiol Dis. 119:113–120. 2018. View Article : Google Scholar : PubMed/NCBI

60 

Alluri H, Grimsley M, Anasooya Shaji C, Varghese KP, Zhang SL, Peddaboina C, Robinson B, Beeram MR, Huang JH and Tharakan B: Attenuation of blood-brain barrier breakdown and hyperpermeability by calpain inhibition. J Biol Chem. 291:26958–26969. 2016. View Article : Google Scholar : PubMed/NCBI

61 

Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M and Hayashi M: Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry. 86:820–822. 2015. View Article : Google Scholar : PubMed/NCBI

62 

Kuijpers M, van Gassen KL, de Graan PN and Gruol D: Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures. J Neuroimmunol. 229:73–80. 2010. View Article : Google Scholar : PubMed/NCBI

63 

Anaparti V, Pascoe CD, Jha A, Mahood TH, Ilarraza 3, Unruh H, Moqbel R and Halayko AJ: Tumor necrosis factor regulates NMDA receptor-mediated airway smooth muscle contractile function and airway responsiveness. Am J Physiol Lung Cell Mol Physiol. 311:L467–480. 2016. View Article : Google Scholar : PubMed/NCBI

64 

Zellinger C, Salvamoser JD, Soerensen J, van Vliet EA, Aronica E, Gorter J and Potschka H: Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model. Epilepsy Res. 108:634–643. 2014. View Article : Google Scholar : PubMed/NCBI

65 

Hung CC, Ho JL, Chang WL, Tai JJ, Hsieh TJ, Hsieh YW and Liou HH: Association of genetic variants in six candidate genes with valproic acid therapy optimization. Pharmacogenomics. 12:1107–1117. 2011. View Article : Google Scholar : PubMed/NCBI

66 

Gautier NM and Glasscock E: Spontaneous seizures in Kcna1-null mice lacking voltage-gated Kv1.1 channels activate Fos expression in select limbic circuits. J Neurochem. 135:157–164. 2015. View Article : Google Scholar : PubMed/NCBI

67 

Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Taracha E, Skórzewska A, Lehner M, Bidziński A, Hamed A, Wisłowska-Stanek A, et al: Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures. Epilepsy Behav. 16:216–224. 2009. View Article : Google Scholar : PubMed/NCBI

68 

Cunningham JT, Mifflin SW, Gould GG and Frazer A: Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology. 33:1884–1895. 2008. View Article : Google Scholar : PubMed/NCBI

69 

Deransart C Lê BT, Marescaux C and Depaulis A: Role of the subthalamo-nigral input in the control of amygdala-kindled seizures in the rat. Brain Res. 807:78–83. 1998. View Article : Google Scholar : PubMed/NCBI

70 

Bozzi Y, Vallone D and Borrelli E: Neuroprotective role of dopamine against hippocampal cell death. J Neurosci. 20:8643–8649. 2000. View Article : Google Scholar : PubMed/NCBI

71 

Madsen TM, Bolwig TG and Mikkelsen JD: Differential regulation of c-Fos and FosB in the rat brain after amygdala kindling. Cell Mol Neurobiol. 26:87–100. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang Y and Li Z: RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy. Exp Ther Med 18: 373-383, 2019.
APA
Wang, Y., & Li, Z. (2019). RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy. Experimental and Therapeutic Medicine, 18, 373-383. https://doi.org/10.3892/etm.2019.7538
MLA
Wang, Y., Li, Z."RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy". Experimental and Therapeutic Medicine 18.1 (2019): 373-383.
Chicago
Wang, Y., Li, Z."RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy". Experimental and Therapeutic Medicine 18, no. 1 (2019): 373-383. https://doi.org/10.3892/etm.2019.7538
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y and Li Z: RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy. Exp Ther Med 18: 373-383, 2019.
APA
Wang, Y., & Li, Z. (2019). RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy. Experimental and Therapeutic Medicine, 18, 373-383. https://doi.org/10.3892/etm.2019.7538
MLA
Wang, Y., Li, Z."RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy". Experimental and Therapeutic Medicine 18.1 (2019): 373-383.
Chicago
Wang, Y., Li, Z."RNA‑seq analysis of blood of valproic acid‑responsive and non‑responsive pediatric patients with epilepsy". Experimental and Therapeutic Medicine 18, no. 1 (2019): 373-383. https://doi.org/10.3892/etm.2019.7538
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team